Karyopharm Therapeutics

Name: Karyopharm Therapeutics
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

width

height

	Ebit		Tarehe
Abbott ABT:US	$ 2563M	1159M	2020-12
Abbvie ABBV:US	$ 4071M	760M	2020-12
Acceleron Pharma XLRN:US	$ -57594000	18.37M	2020-12
Amgen AMGN:US	$ 2008M	445M	2020-12
AstraZeneca AZN:LN	605M	823M	2020-12
Astrazeneca AZN:US	605M	823M	2020-12
Biocryst Pharmaceuticals BCRX:US	$ -52405000	9.54M	2020-12
Bristol Myers Squibb BMY:US	$ 1150M	809M	2020-12
Eli Lilly And LLY:US	$ 2328.3M	948.6M	2020-12
Enanta Pharmaceuticals ENTA:US	$ -12299000	7.48M	2020-12
Epizyme EPZM:US	$ -62145000	7.79M	2020-12
GlaxoSmithKline GSK:LN	1.62B	850M	2020-12
Johnson & Johnson JNJ:US	$ 4542M	1659M	2020-12
Karyopharm Therapeutics KPTI:US	$ -37066000	10.04M	2020-12
Macrogenics MGNX:US	$ -2170000	33.96M	2020-12
Merk MRK:US	$ 283M	3527M	2020-12
Mirati Therapeutics MRTX:US	$ -106335000	17.66M	2020-12
Nektar Therapeutics NKTR:US	$ -110721000	7.67M	2020-12
Novartis NOVN:VX	2.65B	673M	2020-12
Novartis NVS:US	2.65B	673M	2020-12
Pfizer PFE:US	$ 1152M	1309M	2020-12
Regeneron Pharmaceuticals REGN:US	$ 1167M	113.9M	2020-12
Sangamo Biosciences SGMO:US	$ -43432000	39.73M	2020-12
Takeda 4502:JP	163.95B	73.93B	2020-12
Ultragenyx Pharmaceutical RARE:US	$ -96081000	45.77M	2020-12
Xencor XNCR:US	$ -13698000	3.02M	2020-12
YTE INCY:US	$ 180.25M	152.83M	2020-12

Karyopharm Therapeutics - Sasa, maadili, data ya kihistoria, utabiri, takwimu, chati na kalenda ya kiuchumi - Apr 2021.